Lynge Bytorv Fodklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.1% 10.3% 6.4% 4.1% 4.4%  
Credit score (0-100)  21 24 36 49 46  
Credit rating  BB BB BBB BBB BBB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -38.8 145 306 409 441  
EBITDA  -38.8 145 306 409 441  
EBIT  -70.3 113 275 385 441  
Pre-tax profit (PTP)  -83.5 103.8 272.9 381.5 441.0  
Net earnings  -65.1 81.0 212.7 294.7 344.0  
Pre-tax profit without non-rec. items  -83.5 104 273 382 441  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  86.7 55.2 23.6 0.0 0.0  
Shareholders equity total  -15.1 65.9 279 573 444  
Interest-bearing liabilities  249 64.7 0.0 78.6 50.5  
Balance sheet total (assets)  263 158 414 768 621  

Net Debt  150 21.7 -278 -635 -306  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -38.8 145 306 409 441  
Gross profit growth  0.0% 0.0% 112.0% 33.5% 7.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  263 158 414 768 621  
Balance sheet change%  0.0% -39.7% 161.5% 85.6% -19.2%  
Added value  -38.8 144.5 306.4 416.8 441.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  55 -63 -63 -47 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  181.3% 78.2% 89.7% 94.2% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -25.3% 51.8% 96.1% 65.2% 63.5%  
ROI %  -28.2% 59.5% 134.4% 82.8% 76.9%  
ROE %  -24.8% 49.3% 123.5% 69.2% 67.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -5.4% 41.6% 67.3% 74.6% 71.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -387.7% 15.0% -90.6% -155.2% -69.4%  
Gearing %  -1,649.6% 98.2% 0.0% 13.7% 11.4%  
Net interest  0 0 0 0 0  
Financing costs %  10.5% 5.9% 6.2% 9.6% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.5 0.6 2.5 3.7 3.2  
Current Ratio  0.5 0.6 2.5 3.7 3.2  
Cash and cash equivalent  98.6 43.0 277.7 713.3 356.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -148.5 -35.9 208.3 526.6 395.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0